Synthesis, 5-Hydroxytryptamine1A Receptor Affinity and Docking Studies of 3-[3-(4-Aryl-1-piperazinyl)-propyl]-1H-Indole Derivatives

被引:11
|
作者
Pessoa-Mahana, Hernan [1 ]
Ugarte Nunez, Catalina [1 ]
Araya-Maturana, Ramiro [1 ]
Saitz Barria, Claudio [1 ]
Zapata-Torres, Gerald [2 ,3 ]
David Pessoa-Mahana, Carlos [4 ]
Iturriaga-Vasquez, Patricio [3 ,5 ]
Mella-Raipan, Jaime [4 ]
Reyes-Parada, Miguel [3 ,6 ,7 ]
Celis-Barros, Cristian [2 ]
机构
[1] Univ Chile, Fac Chem & Pharmaceut Sci, Dept Organ & Phys Chem, Santiago 1, Chile
[2] Univ Chile, Fac Chem & Pharmaceut Sci, Dept Analyt & Inorgan Chem, Santiago 1, Chile
[3] Millennium Inst Cell Dynam & Biotechnol, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Fac Chem, Dept Pharm, Santiago 22, Chile
[5] Univ Chile, Fac Sci, Dept Chem, Santiago 1, Chile
[6] Univ Santiago Chile, Fac Med Sci, Sch Med, Santiago, Chile
[7] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile
关键词
indolylalkylarylpiperazine; 5-hydroxytryptamine(1A) receptor; docking; binding; synthesis; ARYLPIPERAZINE DERIVATIVES; SUBSTITUTED INDOLES; AUTOMATED DOCKING; 5-HT1A; SEROTONIN; AGONISTS; LIGANDS; ANTIDEPRESSANT; SELECTIVITY; INHIBITORS;
D O I
10.1248/cpb.60.632
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 3-[3-(4-aryl-1-piperazinyl)-propyl]-1H-indole derivatives (12a-h) was synthesized and evaluated for binding affinity at the human 5-hydroxytryptamine(1A) receptor (5-HT1AR) compounds (12b) and (12h) showed the highest 5-HT1A receptor affinity (IC50=15nM). Molecular docking studies with all the compounds in a homology model of 5-HT1A showed that the main interaction anchoring the ligand in the receptor was a charge-reinforced bond between the protonated nitrogen atom (N-4) of the piperazine ring and Aspartate(3.32).
引用
收藏
页码:632 / 638
页数:7
相关论文
共 50 条
  • [1] Biologically active 1-arylpiperazines, synthesis of N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of benzoxazinone and benzoxazolinone
    Kowalski, P
    Mokrosz, MJ
    Majka, Z
    Kowalska, T
    Duszynska, B
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2000, 37 (01) : 187 - 189
  • [2] Process development of 5-fluoro-3-[3-[4-(5-methoxy-4-pyrimidinyl)-1-piperazinyl]propyl]-1H-indole dihydrochloride
    Anderson, NG
    Ary, TD
    Berg, JL
    Bernot, PJ
    Chan, YY
    Chen, CK
    Davies, ML
    DiMarco, JD
    Dennis, RD
    Deshpande, RP
    Do, HD
    Droghini, R
    Early, WA
    Gougoutas, JZ
    Grosso, JA
    Harris, JC
    Haas, OW
    Jass, PA
    Kim, DH
    Kodersha, GA
    Kotnis, AS
    LaJeunesse, J
    Lust, DA
    Madding, GD
    Modi, SP
    Moniot, JL
    Nguyen, A
    Palaniswamy, V
    Phillipson, DW
    Simpson, JH
    Thoraval, D
    Thurston, DA
    Tse, K
    Polomski, RE
    Wedding, DL
    Winter, WJ
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1997, 1 (04) : 300 - 310
  • [3] SYNTHESIS OF 5-FLUORO-3-[3-[4-(2-C-14]-5-METHOXY-4-PYRIMIDINYL)-1 PIPERAZINYL]PROPYL]-1H-INDOLE DIHYDROCHLORIDE
    HAYNES, UJ
    SWIGOR, JE
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1994, 34 (01): : 101 - 106
  • [4] SYNTHESIS OF H-3 LABELED 5-FLUORO-3-[3-[4-(5-METHOXY-4-PYRIMIDINYL)-1-PIPERAZINYL]PROPYL]-1H-INDOLE, A SEROTONERGIC AGENT WITH POTENTIAL ANTIDEPRESSANT ACTIVITY
    DISCHINO, DD
    COMBRINK, KD
    DOWEYKO, L
    MORIMOTO, H
    PEARCE, BC
    WILLIAMS, PG
    YEVICH, JP
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1995, 36 (08): : 789 - 794
  • [5] SYNTHESIS, ANTI-HYPERTENSIVE AND BETA-ADRENORECEPTOR ANTAGONIST ACTIVITIES OF 3-[4-[3-(4-ARYL-1-PIPERAZINYL)-ISOPROPANOLOXY]-PHENYL]-4(3H) QUINAZOLONES
    BOTROS, S
    SAAD, SF
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1989, 24 (06) : 585 - 590
  • [6] Preparation of N-[ω-(4-aryl-1-piperazinyl)ethyl/propyl]-3-hydroxyphthalimidines
    Desai, RA
    Samant, SD
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2000, 39 (06): : 455 - 457
  • [7] SYNTHESIS AND PHARMACOLOGY OF SOME 2-[3-(4-ARYL-1-PIPERAZINYL)PROPYL]-1H-BENZ[DE]ISOQUINOLIN-1,3(2H)-DIONES 2,5-PYRROLIDINEDIONES
    KHADILKAR, BM
    SAMANT, SD
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 1986, 63 (05) : 529 - 530
  • [8] 3-[1-(4-Methylphenylsulfonyl)-1,4-dihydropyridin-4-yl]-1H-indole
    Oliveira-Campos, Ana M. F.
    Ribeiro, Joana M. O.
    Rodrigues, Ligia M.
    Parpot, Pier
    Lopes, Paulo E.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O915 - U3012
  • [9] 3-(2-Methyl-2-nitropropyl)-1H-indole
    Fang, Zheng
    Zhang, Feng
    Zou, Bao-Hua
    Guo, Kai
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1758 - +
  • [10] STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF CNS AGENTS .10. 1-ARYL-2-[3-(4-ARYL-1-PIPERAZINYL)PROPYL]-1,4-DIHYDRO-3(2H)-ISOQUINOLINONES - 2 MODES OF THE INTERACTION WITH THE 5-HT(1A) RECEPTOR-SITE
    MOKROSZ, JL
    BOJARSKI, AJ
    MACKOWIAK, M
    BIELECKA, Z
    BOKSA, J
    PHARMAZIE, 1994, 49 (05): : 328 - 333